Replies to post #188577 on Cytodyn Inc (CYDY)

[Bill_ENG]

At some point international, not United States based media will start reporting on it.

jmo

[Bill_ENG]

Cytodyn will have to be much bigger and stronger than it is currently in order to be able to deal with the FDA and its BP masters.

A win in Brazil and EUAs in other Countries especially if in the UK and Canada could result in collaboration with a BP and get Cytodyn's foot in the door.

Cytodyn cannot deal with a BP from a weak position as it is in currently, they are too vulnerable to a takeover. We can see this from the current attack from a pathetic group of old fogies.

They need to be much bigger and financially stable to deal with a BP and only for one indication with promise.

jmo

[Hookmeistr]

Black-Ops, I'm about 80+% certain that USA major media outlets (non-conservative) will never talk about leronlimab's success abroad, regardless of EUA approvals around the world. I believe you'll eventually begin to hear about it in the conservatives news outlets first. If the liberal outlets talk about it, it will most likely only be to downplay leronlimab and Cytodyn. Such discussions will most likely be carefully coordinated and directed by Big Pharma and what they discuss will be limited to discrediting Cytodyn/leronlimab in order to better serve their own interests. Of that, I'm quite certain.

The only hesitancy comes into play if BP decides to bring leronlimab into their folds (partnership/buyout) and tout it as theirs, and most likely inconjunction with another drug as a combo therapy. I suspect they will give most credit to whatever drug (perhaps phizermectin) they use as a therapy/treatment while only giving nominal credit to leronlimab's role in whatever success they tout.

Call me cynical.